Literature DB >> 17960818

Recreational physical activity and risk of Parkinson's disease.

Evan L Thacker1, Honglei Chen, Alpa V Patel, Marjorie L McCullough, Eugenia E Calle, Michael J Thun, Michael A Schwarzschild, Alberto Ascherio.   

Abstract

The purpose of this study was to investigate associations between recreational physical activity and Parkinson's disease (PD) risk. We prospectively followed 143,325 participants in the Cancer Prevention Study II Nutrition Cohort from 1992 to 2001 (mean age at baseline = 63). Recreational physical activity was estimated at baseline from the reported number of hours per week on average spent performing light intensity activities (walking, dancing) and moderate to vigorous intensity activities (jogging/running, lap swimming, tennis/racquetball, bicycling/stationary bike, aerobics/calisthenics). Incident cases of PD (n = 413) were confirmed by treating physicians and medical record review. Relative risks (RR) were estimated using proportional hazards models, adjusting for age, gender, smoking, and other risk factors. Risk of PD declined in the highest categories of baseline recreational activity. The RR comparing the highest category of total recreational activity (men > or = 23 metabolic equivalent task-hours/week [MET-h/wk], women > or = 18.5 MET-h/wk) to no activity was 0.8 (95% CI: 0.6, 1.2; P trend = 0.07). When light activity and moderate to vigorous activity were examined separately, only the latter was found to be associated with PD risk. The RR comparing the highest category of moderate to vigorous activity (men > or = 16 MET-h/wk, women > or = 11.5 MET-h/wk) to the lowest (0 MET-h/wk) was 0.6 (95% CI: 0.4, 1.0; P trend = 0.02). These results did not differ significantly by gender. The results were similar when we excluded cases with symptom onset in the first 4 years of follow-up. Our results may be explained either by a reduction in PD risk through moderate to vigorous activity, or by decreased baseline recreational activity due to preclinical PD. 2007 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17960818      PMCID: PMC2387117          DOI: 10.1002/mds.21772

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  20 in total

1.  Parkinson's disease over the last 100 years.

Authors:  Donald B Calne
Journal:  Adv Neurol       Date:  2003

2.  Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease.

Authors:  Honglei Chen; Eric Jacobs; Michael A Schwarzschild; Marjorie L McCullough; Eugenia E Calle; Michael J Thun; Alberto Ascherio
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

3.  Regular exercise, anxiety, depression and personality: a population-based study.

Authors:  M H M De Moor; A L Beem; J H Stubbe; D I Boomsma; E J C De Geus
Journal:  Prev Med       Date:  2006-01-24       Impact factor: 4.018

4.  Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF.

Authors:  Ann D Cohen; Jennifer L Tillerson; Amanda D Smith; Timothy Schallert; Michael J Zigmond
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

5.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

Authors:  Andrew J Hughes; Susan E Daniel; Yoav Ben-Shlomo; Andrew J Lees
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

6.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.

Authors:  Eugenia E Calle; Carmen Rodriguez; Eric J Jacobs; M Lyn Almon; Ann Chao; Marjorie L McCullough; Heather S Feigelson; Michael J Thun
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

7.  Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease.

Authors:  A J Hughes; S E Daniel; A J Lees
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

Review 8.  The personality associated with Parkinson's disease.

Authors:  M Menza
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

9.  Recreational physical activity and risk of postmenopausal breast cancer in a large cohort of US women.

Authors:  Alpa V Patel; Eugenia E Callel; Leslie Bernstein; Anna H Wu; Michael J Thun
Journal:  Cancer Causes Control       Date:  2003-08       Impact factor: 2.506

10.  Plasma urate and risk of Parkinson's disease.

Authors:  M G Weisskopf; E O'Reilly; H Chen; M A Schwarzschild; A Ascherio
Journal:  Am J Epidemiol       Date:  2007-06-20       Impact factor: 4.897

View more
  65 in total

Review 1.  Targeted exercise therapy for voice and swallow in persons with Parkinson's disease.

Authors:  John A Russell; Michelle R Ciucci; Nadine P Connor; Timothy Schallert
Journal:  Brain Res       Date:  2010-03-15       Impact factor: 3.252

Review 2.  Missing pieces in the Parkinson's disease puzzle.

Authors:  Jose A Obeso; Maria C Rodriguez-Oroz; Christopher G Goetz; Concepcion Marin; Jeffrey H Kordower; Manuel Rodriguez; Etienne C Hirsch; Matthew Farrer; Anthony H V Schapira; Glenda Halliday
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

3.  An exploratory study of activity in veterans with Parkinson's disease.

Authors:  Marilyn Trail; Nancy J Petersen; Naomi Nelson; Eugene C Lai
Journal:  J Neurol       Date:  2012-08       Impact factor: 4.849

Review 4.  How might physical activity benefit patients with Parkinson disease?

Authors:  Arlène D Speelman; Bart P van de Warrenburg; Marlies van Nimwegen; Giselle M Petzinger; Marten Munneke; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

5.  Effects of a formal exercise program on Parkinson's disease: a pilot study using a delayed start design.

Authors:  A Park; D Zid; J Russell; A Malone; A Rendon; A Wehr; X Li
Journal:  Parkinsonism Relat Disord       Date:  2013-10-15       Impact factor: 4.891

6.  Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse.

Authors:  Beth A Smith; Natalie R S Goldberg; Charles K Meshul
Journal:  Brain Res       Date:  2011-03-21       Impact factor: 3.252

7.  Assessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson's disease.

Authors:  Jacqueline R Kane; Michelle R Ciucci; Amber N Jacobs; Nathan Tews; John A Russell; Allison M Ahrens; Sean T Ma; Joshua M Britt; Lawrence K Cormack; Timothy Schallert
Journal:  J Commun Disord       Date:  2011-04-30       Impact factor: 2.288

8.  Low muscle strength in late adolescence and Parkinson disease later in life.

Authors:  Helena Gustafsson; Jan Aasly; Stefan Stråhle; Anna Nordström; Peter Nordström
Journal:  Neurology       Date:  2015-04-03       Impact factor: 9.910

9.  Use of antidepressants and the risk of Parkinson's disease: a prospective study.

Authors:  A Alonso; L A García Rodríguez; G Logroscino; M A Hernán
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-06       Impact factor: 10.154

Review 10.  Does the difference between physically active and couch potato lie in the dopamine system?

Authors:  Amy M Knab; J Timothy Lightfoot
Journal:  Int J Biol Sci       Date:  2010-03-09       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.